Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rai

Showing results (441-450 of 543) with videos related to

Pageof 55
Sort By:
Blood|January 30, 2010
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originCharles C Chu, Rosa Catera, Lu Zhang, et al.
Seminars in Oncology|June 1, 1987
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group BR J Mayer, C A Schiffer, B A Peterson, et al.
ACS Omega|March 7, 2022
Bioinspired NiO Nanospheres: Exploring <i>In Vitro</i> Toxicity Using Bm-17 and <i>L. rohita</i> Liver Cells, DNA Degradation, Docking, and Proposed Vacuolization MechanismPrashant B Chouke, Ajay K Potbhare, Nitin P Meshram, et al.
Molecular Medicine (Cambridge, Mass.)|January 23, 2015
Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like ReceptorNino Porakishvili, Ketki Vispute, Andrew J Steele, et al.
The European Respiratory Journal|October 1, 2003
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8T M Bull, C D Cool, A E Serls, et al.
Blood|September 25, 2008
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIACharles C Chu, Rosa Catera, Katerina Hatzi, et al.
Seminars in Oncology|June 1, 1985
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I studyR J Mayer, C A Schiffer, B A Peterson, et al.
The New England Journal of Medicine|December 15, 2000
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemiaK R Rai, B L Peterson, F R Appelbaum, et al.
Blood|August 7, 2007
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3George F Widhopf, Craig J Goldberg, Traci L Toy, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
Pageof 55

Showing results (441-450 of 543) with videos related to

Sort By:
Pageof 55
Blood|January 30, 2010
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originCharles C Chu, Rosa Catera, Lu Zhang, et al.
Seminars in Oncology|June 1, 1987
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group BR J Mayer, C A Schiffer, B A Peterson, et al.
ACS Omega|March 7, 2022
Bioinspired NiO Nanospheres: Exploring <i>In Vitro</i> Toxicity Using Bm-17 and <i>L. rohita</i> Liver Cells, DNA Degradation, Docking, and Proposed Vacuolization MechanismPrashant B Chouke, Ajay K Potbhare, Nitin P Meshram, et al.
Molecular Medicine (Cambridge, Mass.)|January 23, 2015
Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like ReceptorNino Porakishvili, Ketki Vispute, Andrew J Steele, et al.
The European Respiratory Journal|October 1, 2003
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8T M Bull, C D Cool, A E Serls, et al.
Blood|September 25, 2008
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIACharles C Chu, Rosa Catera, Katerina Hatzi, et al.
Seminars in Oncology|June 1, 1985
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I studyR J Mayer, C A Schiffer, B A Peterson, et al.
The New England Journal of Medicine|December 15, 2000
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemiaK R Rai, B L Peterson, F R Appelbaum, et al.
Blood|August 7, 2007
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3George F Widhopf, Craig J Goldberg, Traci L Toy, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
Pageof 55